Local Institution - 0113

Toronto, Ontario M5G 2M9

1 studies enrolling now · 2 studies all time

What they study most

Autism-Related Irritability, Schizophrenia, Stage IV or Recurrent Non-Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively — Recruiting now
• An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) — Completed